when should aml patients consider joining a clinical trial?
Published 1 year ago • 36 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
3:34
is it safe? breaking down the clinical trial process
-
1:51
how does patient clinical trial participation move cll research forward?
-
12:03
aml treatment approaches | factors that impact options
-
3:55
understanding aml treatment categories
-
2:18
aml treatment options: what’s available?
-
2:21
aml research: what’s new in treatment?
-
3:47
combination aml therapy for newly diagnosed patients | what are the long-term effects?
-
4:12
what promising aml treatments are available for newly diagnosed patients?
-
0:31
what is the role of bone marrow biopsies in aml treatment?
-
2:35
what key testing occurs following an aml diagnosis?
-
29:35
what time is the right time for transplantation?
-
1:28:37
cpag webinar: working with industry in the conduct of clinical trials 1
-
2:43
clinical trials underway for new aml treatment
-
5:32
building knowledge & competencies for patient involvement in clinical trials: a joint venture
-
53:08
mpn specialized care and technology: the ongoing role of telemedicine
-
1:55
how can precision medicine improve outcomes in older patients with aml?
-
2:09
could aspacytarabine be a new frontline therapy option for patients with aml that are unfit for ic?
-
3:28
the role of the b-cell receptor and other signaling pathways in cll
-
1:02:32
advocacy grand rounds: accelerated approval reforms: balancing timely access & true clinical benefit